CoASH has a central role in intermediary metabolism. The utilization of dietary fatty acids depends mainly on their prior conversion t o CoA-esters by several acyl-CoA synthases of broad specificity. Cells need t o maintain [acyl-CoA] secondary t o the inhibition of specific enzymes, and other metabolic disturbances, for example of gluconeogenesis and ureogenesis, may also occur.
A number of mechanisnis have been evolved which oppose or limit excessive acylation of CoA, although the metabolism o f individual carboxylic acids and their CoAesters is different depending o n the specificities of the enzymes involved. These mechanisms will be outlined. followed by a discussion of some inhibitors o f mitochondrial fatty acid oxidation which give unusual acylCoA esters in vivo. Further references are given in reviews (Sherratt, 1969 (Sherratt, , 1981 Stewart & Hanley, 1969; Sherratt & Osmundsen, 1976; Senior et al., 1975; Sherratt et al., 1976 Sherratt et al., , 1985 Sherratt & Veitch. 1984; Turnbull. 1983) .
Enzymes opposing excessive acylation of CoA Acyl-CoA hydrolases. There are a number of acyl-CoA hydrolases in various cell compartments, including poorly characterized short-and medium-chain hydrolases in the mitochondrial matrix (see Sherratt & Osniundsen, 1976) . These enzymes appear t o have high K , valucs (in the niM range) for several acyl-CoA esters and to show product inhibition by CoASH. Most enzymes acting on CoA esters involved in intermediary metabolism have low K , values (in the /JM range) for their substrates. tlence the kinetic properties of these acyl-CoA hydrolases appear well suited t o oppose excessive acylation of mitochondrial CoA without causing appreciable futile cycling between acylCoA esters and the corresponding carboxylic acids in the same cell compartment, unless the ester conccntratioii increases t o abnormal values for any reason.
Camitine acy Itransferuses. The ca rni t ine ac y It ra nsfe ra ses associated with the inner niitochondrial membrane and the peroxisomes catalyse the exchange reaction between acylCoA and carnitine:
Many short-and medium-chain acyl-CoA esters are substrates for carnitine acetyltransferase located largely on the inner face of the inner mitochondrial iiienibr;lne and in peroxisomes, although branched-chain acyl-CoA esters react much less readily than acetyl-CoA o r butyryl-CoA (Solberg & Bremer, 1970) . Acyl-CoA and carnitine act as acyl buffers, and may be important in ruminants which absorb large quantities of acetate, propionate and butyrate formed in the rumen. In sonie inborn errors of metabolism in which acyl-CoA esters accumulate abnormally, there may be chronic excretion of the corresponding acyl-carnitine esters leading t o secondary carnitine deficiency (see Sherratt & Veitch, 1984) .
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Gly cine N-acy ltrans ferase. The Co A -e st er s of many xenobiotic carboxylic acids, including of some aromatic carboxylic acids, form glycine conjugates in the mitochondrial matrix, catalysed by glycine N-acylase (Bartlett & Gonipertz, 1974; Gatley & Sherratt, 1977) :
This enzyme has low K , values (pM) for the CoA-esters of many xenobiotics, but has higher affinities for most 'physiological' CoA-esters, and a high K , for glycine (3.3 niM ) (Bartlett & Goinpert/., 1974) . so that boosting tissue concentrations of glycine by administering large amounts of glycine increases the rate of conjugation (Al-Bassarn & Sherratt, 1981) .
Isovaleryl-CoA, which accumulates in isovaleric acidaemia and in hypoglycin poisoning. is mainly deacylated to isovaleric acid or conjugated with glycine t o from isovalerylglycinc (Tanaka. 1972) . but is a very poor substrate for the carnitine acyltransterases.
Inhibitors of mitochondria1 fatty acid oxidation
The mitochondria1 oxidation of longchain fatty acids is carnitine dependent. Short-chain and medium-chain fatty acids enter the mitochondrial matrix by diffusion across the inner membrane where they may be converted t o their acyl-CoA esters by butyryl-CoA synthase which has broad specificity. This conversion is facilitated by higher concentrations of fatty acids in the matrix than in the cytosol because of the more alkaline conditions in the matrix. Inhibitors can act on the cytosolic face of the mitochondrial inner membrane t o prevent entry of longchain fatty acyl-groups or directly on 0-oxidation in the matrix.
2-Oxiranecarboxylates. The observation that 2-bromopalmitate (as its CoA and carnitine esters) is a powerful inhibitor of the oxidation of longchain fatty acids (Chase & Tubbs, 1972) found that (R)-2-TDGA-CoA, but not (S)-2-TDGA-CoA, inhibits CPT 1. It is not known whether inhibition by POCA-CoA is wholly or partly irreversible (Bartlett et al., 1984) but 2-TDGA-CoA appears to combine covalently with CPT 1 (Kiorpes et al., 1984) . CPT I in various tissues is inhibited by nialonyl-CoA, an obligatory intermediate of fatty acid biosynthesis. In liver malonyl-CoA decreases the oxidation of long-chain fatty acids in the fed state when Fatty acid synthesis from glucose occurs. but not during lasting. Similarly to inhibition by malonyl-CoA, oxidation of palmitoyl-CoA is inore sensitive t o inhibition by 2-TDGA-CoA or by POCA-CoA in liver mitochondria from fed than from 2411-fasted rats (Turnbull et al., 1984) , whilc in niuscle mitochondria inhibition by these compounds is not changed by the nutritional state (Bartlett ct al., 1984) . Hvpoglvcin. Hypoglycin (methylenecyclopropylalaninc) is the toxic hypoglycaemic principle of the Jamaican ackee fruit. The discovery that fatty acid oxidation is impaired after ingesting hypoglycin (von Holt et al., 1966) led to a sustained interest in this compound, and in pent-4-enoic acid, which is often wrongly thought to be an analogue of hypoglycin.
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Hypoglycine is transaminated in the cytosol t o methylenecyclopropylpyruvate (MCPP), which is then oxidatively deaminated t o methylenecyclopropylacetylCoA (MCPA-CoA) in the mitochondrial matrix. MCPA-CoA inactivates several, but not all, acyl-CoA dehydrogenases by forming adducts with their FAD prosthetic groups (Wenz et al., 1981) . Rat liver mitochondria only oxidize palmitoyl-CoA incompletely:
Palmitoyl-CoA + 602 -+ 3-acetoacetate + butyrate + CoASH because butyryl-CoA and medium-chain acyl-CoA dehydrogenases, but not palmitoylCoA dehydrogenase, are inactivated. Butyryl-CoA accumulates in the matrix t o a concentration where CoASH is recycled by the action of the high-K, acyl-CoA hydrolase, and this step apparently sets the overall rate of partial 0-oxidation (Billington et al. 1978) . Further, there is also a massive dicarboxylic aciduria in hypoglycin-poisoned animals (Tanaka, 1972) . In liver, the excess free longchain fatty acids are converted t o dicarboxylic acids by w-oxidation in the endoplasmic reticulum. These then form their mono-CoA esters, which undergo partial 0-oxidation in the peroxisomes followed by deacylation t o give medium-chain dicarboxylic acids (see Sherratt & Veitch, 1984; J. Vamecq & F . Van Hoof, unpublished work) . MCPA-CoA also blocks the metabolism of leucine and isoleucine by inactivating isovalerylCoA and 2-niethylbutyryl-CoA dehydrogenases.
Pent-4-enoate (pent-Cenoic acid)
. and showed that pent-4-enoate (Anderson et al., 1958; Yardley & Godfrey, 1967 ) strongly inhibits palmitate oxidation by rat liver mitochondria at low concentrations (20pM), while some other short-chain fatty acids are much less effective. Further, all fatty acids including pent-4-enoate only inhibit pyruvate oxidation weakly. For this reason it is unlikely that simple unavailability of CoASH, due to formation of pent4enoyl-CoA ('CoA-sequestration'), is the main mechanism of inhibition of substrate oxidations. In accord with this, Schulz (1983) demonstrated that 3-oxopent-4-enoyl-CoA, a metabolite of pent-4-enoyl-CoA, inactivates mitochondrial acetoacetylCoA and 3-oxoacylCoA thiolases.
Much higher concentrations (> 1 mM) are required t o inhibit 0-oxidation in perfused rat livers and isolated hepatocytes than in mitochondrial preparations (see Billington et al., 1978) . In some conditions, tissues may oxidize pent-4enoate rapidly by 0-oxidation:
Penta-2,4-dienoyl-CoA is reduced t o pent-2enoyl-CoA by the NADPH-linked 4-enoyl-CoA reductase, an auxiliary enzyme of 0-oxidation important for the metabolism of polyunsaturated fatty acids (Borrebaek et al., 1980; Osmundsen et al., 1982) . When this pathway is overwhelmed with high concentrations of p e n t 4 e n o a t e , or is inoperative because of lack of NADPH, some penta-2,4-dienoyl-CoA is metabolized t o the very potent inhibitor 3 -0xopent-4-enoyl-CoA :
Penta-2,4-dienoyl-CoA -+ 3-hydroxypent-4-enoyl-CoA -+
3-oxopent4enoylCoA
By contrast with hypoglycin, metabolites of pent4-enoate d o not inhibit the degradation of leucine and isoleucine. Miscellaneous compounds. Other inhibitors of mitochondrial 0-oxidation include 2-bromo-octanoatc, 4-bromo-BIOCHEMICAL SOCIETY TRANSACTIONS crotonate and mercaptoacetate. 4-Bronio-octanoate forms 4-bromo-octanoyl-CoA in mitochondria, and this is then converted to 2-bromo-3-0x0-octanoyl-CoA. This inactivates 2-oxoacylCoA thiolase (Raaka & Lowenstein, 198 1) . Similarly, 4-bromocrotonate is converted t o 3-0x04-bromobutyrylCoA, which inactivates acetoacetyl-CoA thiolase (Olowe & Schulz, 1982) . 2-Mercaptoacetate inhibits fatty acid oxidation in coupled, but not uncoupled, rat liver mitochondria, presumably because formation of mercaptoacetyl-CoA is required (BauchC et al., 1981, 1982) . However, the conclusion that palmitoyl-CoA dehydrogenase is necessarily inhibited (BauchC et al., 1981) may be challenged since the spectrophotometric assay used (Osmundsen & Bremer, 1977) measures the flux through 0-oxidation and not just that through palmitoyl-CoA dehydrogenase. Other examples of xenobiotics forming acyl-CoA esters which are potent enzyme inhibitors are known (see, for example, Caldwell, 1984) .
Valproate. Valproate (dipropylacetate) is a widely used and effective anti-epileptic drug and its anti-epileptic effects are thought to be due to free valproate (Becker & Harris, 1983) . Rare cases of valproate-associated hepatotoxicity are encountered, including the development of a fatty liver which may be caused by disturbances of intermediary metabolism (Turnbull, 1983 . This is a rather higher [CoASH] than usually used in enzyme assays in vitro. Cytosolic [CoASHJ is much lower, but tissue [carnitine] is about 1 mM and may act as a 'sink' for acyl-groups if the corresponding acyl-CoA esters are substrates for carnitine acyltransferases. These considerations make simple depletion of [CoASH] unlikely as a primary cause of the biochemical effects of those xenobiotics which give acyl-CoA esters. It must, however, be remembered that the extent of binding of CoASH t o cellular macromolecules is unknown, nor is it known whether the K , values for CoASH of the enzymes involved with the metabolism of xenobiotics as determined in vitru are the same as those found in vivo. However, the marked pharmacological and toxic effects of some xenobiotics can be only be explained by the formation of their unique CoA-esters and/or their unique metabolites.
